Addiction and Substance Use Studies
The purpose of this study is to see how well pioglitazone improves the chances of recovery in people who have recently stopped using cocaine when combined with a type of talk therapy called cognitive behavioral therapy (CBT).
The purpose of this study is to determine if exenatide – an FDA-approved drug for glycemic control – increases the number of people who successfully quit smoking at the end of their treatment and helps with reducing post-cessation weight gain.
Researchers want to investigate whether this medication could be beneficial for people who want to quit smoking and assess its impact on relapse risks such as cravings, withdrawal symptoms, and stress reactivity.
This study aims to explore the feasibility and impact of 28-days of monitored abstinence from cannabis on people living with HIV, who use cannabis weekly or more often.
This study aims to investigate how pioglitazone affects the risk of relapse triggered by stress, its effects on drinking behavior, stress/anxiety, and alcohol cravings in real-life situations for persons with excessive alcohol use.
The purpose of this study is to investigate the effects of naltrexone-bupropion combination pharmacotherapy on smoking behavior and METH use, to test efficacy, and examine drug craving and reward mechanisms.
Researchers want to investigate whether suvorexant could be beneficial for people with methamphetamine use and how it can impact relapse risk.